Immunotherapy in cancer treatment

Details for Australian Patent Application No. 2003269760 (hide)

International Classifications

Event Publications

15 January 2004 Complete Application Filed

Priority application(s): 02022787.2 11.10.02 EP

3 June 2004 Application Open to Public Inspection

Published as AU-B-2003269760

13 April 2006 Assignment before Grant

Sahltech I Goteborg AB The application has been assigned to Sentoclone Therapeutics AB

28 August 2008 Application Accepted

Published as AU-B-2003269760

6 November 2008 Alteration of Name

The name of the applicant has been altered to Sentoclone AB

8 January 2009 Standard Patent Sealed

7 April 2011 Alteration of Name

The name of the patentee has been altered to SentoClone International AB 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.